This undated photo provided by Amarin in November 2018 shows a capsule of the purified, prescription fish oil Vascepa. On Friday, Dec. 13, 2019, U.S. regulators approved expanded use of the medication for preventing serious heart complications in high-risk patients already taking cholesterol-lowering pills. (Amarin via AP)

US approves fish oil-based drug for cutting heart risks

In surprise decision, US approves muscular dystrophy drug

How tramadol, touted as safer opioid, became 3rd world peril

Peter Frates, known for ice bucket challenge, laid to rest

Tramadol is an odd, unpredictable opioid, scientists say

California considers requiring zero emission truck sales

More people signing up for health insurance in California

Eyeing 2020, House empowers Medicare to negotiate drug costs

Outdated, dangerous childbirth practices persist in Europe

Vaping illness death count surpasses 50 in US

California calls pot smoke, THC a risk to moms-to-be

More Americans are dying at home rather than in hospitals

Rep. Ted Lieu of California recovering after heart procedure

New drugs show rare promise against advanced breast cancer

UN: Nearly a half-billion in Asia-Pacific still going hungry

Study: Claim lines for Lyme disease up 117% since 2007

Report: black lung funding cut will cost taxpayers billions

White House backs emerging deal on consumer health costs